Zobrazeno 1 - 10
of 55
pro vyhledávání: '"İkbal Ok Bozkaya"'
Autor:
Özge Aylin Boran, İkbal Ok Bozkaya, Mehtap Olcar Kanbur, Özlem Arman Bilir, Namık Yaşar Özbek
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S28- (2023)
Objective: Hematopoietic stem cell transplantation (HSCT) is an important treatment modality for leukemia, the most common childhood malignancy. Graft versus host disease, one of the most important complication of transplantation, is the most importa
Externí odkaz:
https://doaj.org/article/909d1083b2bc4708b2d9fb3067acc0d9
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss , Pp S45- (2023)
Objective: The aim of this study is to determine the frequency and causative virus of viral infections seen after hematopoietic stem cell transplantation (HSCT) in pedaitric patients, the effect of the immunosuppresive agents and antiviral prophylaxi
Externí odkaz:
https://doaj.org/article/828fc27a36d34d1fba53f201d9a0af1b
Autor:
Ayça Koca Yozgat, Ikbal Ok Bozkaya, Tekin Aksu, Pamir Isik, Mehtap Kanbur, Tugrul Tiryaki, Nese Yarali, Namik Yasar Özbek
Publikováno v:
Indian Journal of Transplantation, Vol 16, Iss 2, Pp 174-179 (2022)
Purpose: Hemorrhagic cystitis (HC) which occurs in 9%–31% of recipients after hematopoietic stem cell transplantation (HSCT) is an important cause of morbidity and mortality. Various treatment approaches have been applied for such as conservative t
Externí odkaz:
https://doaj.org/article/4774ec2133634c86a7904e96568fd5d1
Autor:
Yunus Murat Akcabelen, Dilek Kaçar, Ayça Koca Yozgat, Özlem Arman Bilir, Dilek Gürlek Gökçebay, Turan Bayhan, İkbal Ok Bozkaya, Namık Yaşar Özbek, Neşe Yaralı
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S25- (2021)
Objective: In the 5-year follow-up of patients diagnosed with Juvenile Myelomonocytic Leukemia (JMML) in a single center; reveal treatment and survival analyzes Methodology: In this study, clinical and laboratory data of 12 JMML patients followed in
Externí odkaz:
https://doaj.org/article/a72aeab0c8db4fee96fe6f0fc022886b
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S28- (2021)
Objective: Hematopoietic stem cell transplantation (HSCT) is used in many malignant and non-malignant diseases in pediatric patients. Peripheral blood (PB), bone marrow (BM) or cord blood can be used as a graft source. In this study, it was aimed to
Externí odkaz:
https://doaj.org/article/3bf60d2fb8004d7786c39f4707a165c1
Autor:
Dilek GURLEK GOKCEBAY, Aslı TURGUTOGLU YILMAZ, İkbal Ok Bozkaya, Neşe Yaralı, Namık Yaşar Özbek, Beytullah Şantaflıoğlu
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S28- (2021)
Objective: Fresh frozen plasma (FFP) is the primary source of coagulation factors. Indications of FFP use are very limited such as disseminated intravascular coagulation, massive bleeding, thrombotic thrombocytopenic purpura, biopsy for chronic liver
Externí odkaz:
https://doaj.org/article/df9ff6b89b3f45629862a31017c1e07b
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S62- (2021)
Objective: Busulfan is a widely used alkylating drug for conditioning of hematopoietic stem cell transplantation (HSCT). Higher exposure of Bu is associated with toxicity and (sinusoidal obstruction syndrome) SOS, whereas lower exposure is associated
Externí odkaz:
https://doaj.org/article/fa589eab85c64341a65175faae1192f6
Publikováno v:
Turkish Journal of Hematology, Vol 32, Iss 2, Pp 172-174 (2015)
Congenital amegakaryocytic thrombocytopenia (CAMT) generally begins at birth with severe thrombocytopenia and progresses to pancytopenia. It is caused by mutations in the thrombopoietin receptor gene, the myeloproliferative leukemia virus oncogene (c
Externí odkaz:
https://doaj.org/article/7ac6280e78b948fdaa4d80cbfd108a28
Autor:
Ahmet ERTÜRK, Can ÖZTORUN, Süleyman Arif BOSTANCI, Gökhan DEMİRTAŞ, Serhat EMEKSİZ, Müjdem Nur AZILI, İkbal OK BOZKAYA, Namık Yaşar ÖZBEK, Sabri DEMİR, Emrah ŞENEL
Publikováno v:
Turkish Journal of Pediatric Disease. :1-5
Objective: In our study, we aimed to analyze the use of Therapeutic plasma exchange (TPE) in the manage-ment of septic and Thrombocytopenia-associated multiple-organ failure (TAMOF) in the burn in-tensive care unit of a children’s hospital retrospe
Autor:
Begüm Avcı, Özlem Arman Bilir, Sare Gülfem Özlü, Şerife Mehtap Kanbur, Dilek Gürlek Gökçebay, İkbal Ok Bozkaya, Umut Selda Bayrakçı, Namık Yaşar Özbek
Background Acute kidney injury (AKI) is common complication of hematopoietic stem cell transplantation (HSCT) with increased mortality and morbidity. Understading the risk factors for AKI is essential. The aim of this study is to identify AKI inciden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::63af644dbdc1408bd1051af13853705e
https://doi.org/10.21203/rs.3.rs-2971329/v1
https://doi.org/10.21203/rs.3.rs-2971329/v1